UBS AM’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$201K Sell
550
-13
-2% -$4.88K ﹤0.01% 2721
2026
Q1
$159K Buy
563
+467
+486% +$135K ﹤0.01% 2774
2025
Q4
$28.4K Buy
+96
New +$28.9K ﹤0.01% 2691
2025
Q3
Sell
-105,764
Closed -$16.5M 2351
2025
Q2
$16.5M Buy
105,764
+23,591
+29% +$2.51M ﹤0.01% 1126
2025
Q1
$6.48M Sell
82,173
-60,323
-42% -$6.4M ﹤0.01% 1435
2024
Q4
$13.2M Sell
142,496
-4,407
-3% -$345K ﹤0.01% 1125
2024
Q3
$7.51M Sell
146,903
-15,087
-9% -$780K ﹤0.01% 1363
2024
Q2
$9.29M Buy
+161,990
New +$8.17M ﹤0.01% 1167

Other funds holding CLS

UBS AM's CLS Position: Q2 2026 in Review

UBS AM reduced its Celestica (CLS) stake by 2.3% in Q2 2026, selling an estimated $4.88K and leaving 550 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #2721.

UBS AM first reported a position in CLS in Q2 2024 and has held it in 8 quarters since. The position peaked at $16.5M in Q2 2025. 875 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • UBS AM held 550 shares of Celestica worth $201K as of Q2 2026.
  • UBS AM sold 13 Celestica shares in Q2 2026, an estimated $4.88K.
  • Celestica made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2721 holding.
  • UBS AM first reported a position in Celestica in Q2 2024 and has held it in 8 quarters since.
  • UBS AM's Celestica position peaked at $16.5M in Q2 2025.
  • 875 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.